Stocks›PCRX›Earnings

Pacira BioSciences earnings

When PCRX reports, and what its stock did after each report.

Next report

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 6, 2025 and Nov 6, 2024, after the close.

Who else reports that week: the earnings calendar.

Last report: Aug 4, 2026, 16:03 ET (after the close). The filing on SEC EDGAR ↗

After each report

SEC EDGAR · 1D EOD

Across the last 5 reports we hold closes for, the first close moved a median 4.50% either way. Up 1 of 5.

Moves are only shown for reports where we hold closing prices.

  1. Aug 4, 202616:03 ET · after the close8-K ↗−9.96%1DRevenue $192.4M+6.2% y/yEPS $0.12quarter to Jun 30, 2026
  2. Apr 30, 202616:03 ET · after the close8-K ↗−4.12%1DRevenue $177.4M+5.0% y/yEPS $0.07quarter to Mar 31, 2026
  3. Feb 26, 202616:02 ET · after the close8-K ↗−3.01%1DRevenue $196.9M+5.1% y/yquarter to Dec 31, 2025
  4. Jan 8, 202616:02 ET · after the close8-K ↗−9.57%1DRevenue $196.9M+5.1% y/yquarter to Dec 31, 2025
  5. Nov 6, 202516:04 ET · after the close8-K ↗+4.50%1DRevenue $179.5M+6.5% y/yEPS $0.12quarter to Sep 30, 2025
  6. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
  7. Aug 5, 202516:01 ET · after the close8-K ↗Revenue $181.1M+1.7% y/yEPS −$0.11quarter to Jun 30, 2025
  8. May 8, 202516:06 ET · after the close8-K ↗Revenue $168.9M+1.1% y/yEPS $0.10quarter to Mar 31, 2025
  9. Feb 27, 202516:06 ET · after the close8-K ↗Revenue $187.3M+3.3% y/yquarter to Dec 31, 2024
  10. Jan 10, 202508:01 ET · before the open8-K ↗Revenue $187.3M+3.3% y/yquarter to Dec 31, 2024
  11. Nov 6, 202416:00 ET · after the close8-K ↗Revenue $168.6M+2.8% y/yEPS −$3.11quarter to Sep 30, 2024
  12. Jul 30, 202416:01 ET · after the close8-K ↗Revenue $178.0M+5.0% y/yEPS $0.39quarter to Jun 30, 2024
  13. May 7, 202416:01 ET · after the close8-K ↗Revenue $167.1M+4.2% y/yEPS $0.19quarter to Mar 31, 2024
  14. Feb 29, 202408:03 ET · before the open8-K ↗Revenue $181.2M+5.4% y/yquarter to Dec 31, 2023
  15. Jan 4, 202417:02 ET · after the close8-K ↗Revenue $181.2M+5.4% y/yquarter to Dec 31, 2023
  16. Nov 2, 202308:01 ET · before the open8-K ↗Revenue $163.9M−2.1% y/yEPS $0.23quarter to Sep 30, 2023
  17. Aug 2, 202308:02 ET · before the open8-K ↗Revenue $169.5M0.0% y/yEPS $0.51quarter to Jun 30, 2023

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. Prior-session closes only; not a forecast, not advice.

PCRX: stories, the record and filings →